Literature DB >> 2991595

Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance.

H Ikeda, F Laigret, M A Martin, R Repaske.   

Abstract

The murine leukemia virus (MuLV) sequence associated with the resistance allele of the Fv-4 gene (Fv-4r) was molecularly cloned from genomic DNA of uninfected mice carrying this allele. The 5.2-kilobase cloned EcoRI DNA fragment (pFv4) was shown by nucleotide sequencing to contain 3.4 kilobases of a colinear MuLV-related proviral sequence which began in the C-terminal end of the pol region and extended through the env region and the 3' long terminal repeat. Cellular sequences flanked the 3' as well as the 5' ends of the truncated MuLV sequence. Alignment of the N-terminal half of the pFv4 env sequence with ecotropic, mink cell focus-forming, and xenotropic MuLV env sequences established the relatedness of pFv4 and ecotropic MuLV env sequences. A subcloned 700-base pair segment (pFv4env) from the 5' env region of pFv4 was used as an Fv-4-specific probe; it hybridized specifically to the Fv-4r-associated proviral sequence but not to endogenous ecotropic MuLV proviral DNA under high stringency. All Fv-4-resistant mice contained the same retroviral segment associated with the same flanking cellular DNA. Expression of Fv-4r-specific mRNA was demonstrated in the spleens of Fv-4r mice but not Fv-4s mice, supporting the previously proposed resistance model based on interference.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991595      PMCID: PMC255061     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Nucleotide sequence of AKV murine leukemia virus.

Authors:  W Herr
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

3.  Molecular basis of host range variation in avian retroviruses.

Authors:  A J Dorner; J P Stoye; J M Coffin
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus.

Authors:  R R O'Neill; C E Buckler; T S Theodore; M A Martin; R Repaske
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  A unique sequence related to the ecotropic murine leukemia virus is associated with the Fv-4 resistance gene.

Authors:  C A Kozak; N J Gromet; H Ikeda; C E Buckler
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

6.  Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses.

Authors:  A S Khan
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  Evidence for a new form of retroviral env transcript in leukemic and normal mouse lymphoid cells.

Authors:  M Boccara; M Souyri; C Magarian; E Stavnezer; E Fleissner
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

8.  A cell membrane "gp70" associated with Fv-4 gene: immunological characterization, and tissue and strain distribution.

Authors:  H Ikeda; T Odaka
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

9.  Murine retroviral restriction genes Fv-4 and Akvr-1 are alleles of a single locus.

Authors:  S J O'Brien; E J Berman; J D Estes; M B Gardner
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  64 in total

1.  Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).

Authors:  A Nihrane; J Silver
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Interference established in mice by infection with Friend murine leukemia virus.

Authors:  T Mitchell; R Risser
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

Review 3.  Evolution of different antiviral strategies in wild mouse populations exposed to different gammaretroviruses.

Authors:  Christine A Kozak
Journal:  Curr Opin Virol       Date:  2013-08-28       Impact factor: 7.090

4.  Potential progenitor sequences of mink cell focus-forming (MCF) murine leukemia viruses: ecotropic, xenotropic, and MCF-related viral RNAs are detected concurrently in thymus tissues of AKR mice.

Authors:  F Laigret; R Repaske; K Boulukos; A B Rabson; A S Khan
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Avian endogenous provirus (ev-3) env gene sequencing: implication for pathogenic retrovirus origination.

Authors:  A T Tikhonenko; O L Lomovskaya
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

6.  Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties.

Authors:  H Ikeda; H Sugimura
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

Review 7.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

8.  Fv-4: identification of the defect in Env and the mechanism of resistance to ecotropic murine leukemia virus.

Authors:  G M Taylor; Y Gao; D A Sanders
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 9.  Murine endogenous retroviruses.

Authors:  C Stocking; C A Kozak
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

10.  Inhibition of murine AIDS (MAIDS), development by the transplantation of bone marrow cells carrying the Fv-4 resistance gene to MAIDS virus-infected mice.

Authors:  Y Nakagawa; K Kakimi; W Ling; Y Kubo; K Higo; T Masuda; K Kuribayashi; M Iwashiro; Y Komatz; T Hirama
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.